SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-20-275192
Filing Date
2020-10-23
Accepted
2020-10-23 13:11:28
Documents
1
Effectiveness Date
2020-10-23

Document Format Files

Seq Description Document Type Size
1 15-12B d72797d1512b.htm 15-12B 10215
  Complete submission text file 0001193125-20-275192.txt   11349
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12B | Act: 34 | File No.: 001-37519 | Film No.: 201257030
SIC: 2834 Pharmaceutical Preparations